GSK-PAR 29060 637

A double-blind, placebo controlled study to evaluate the efficacy and tolerability of paroxetine in patients with Generalised Anxiety Disorder (GAD)
PAR 29060 637
Anxiety Disorders
Phase 3
The data from this study is provided in combined datasets containing data from other paroxetine studies. A raw dataset, an annotated case report form, a reporting and analysis plan, a clinical study report, and a protocol are not available for this study. A link to and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies.
December 2014